Status:
COMPLETED
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Crohn Disease
Eligibility:
All Genders
18-70 years
Brief Summary
From January 2020 to January 2025, Crohn's disease (CD) patients and gender- and age-matched normal controls were collected from the Department of Gastroenterology, the Second Affiliated Hospital of W...
Detailed Description
From January 2020 to January 2025, a total of 311 CD patients and 495 gender- and age-matched normal controls were collected from the Department of Gastroenterology, the Second Affiliated Hospital of ...
Eligibility Criteria
Inclusion
- diagnosed CD based on comprehensive clinical, colonoscopy, histopathological, laboratory, and radiographic examination results
Exclusion
- rheumatoid arthritis, systemic lupus erythematosus, intestinal tuberculosis, ischemic enteritis, radiation enteritis, tumors, etc.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2025
Estimated Enrollment :
906 Patients enrolled
Trial Details
Trial ID
NCT06935942
Start Date
January 1 2020
End Date
January 1 2025
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325000